Brief: Investor Group Urges Pasithea Therapeutics Board To Schedule Special Meeting
13/10/2022 21:05
Oct 13 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* INVESTOR GROUP COMMENTS ON PASITHEA THERAPEUTICS’
SEEMINGLY
DEFENSIVE AND ILL-TIMED ACQUISITION OF ALLOMEK THERAPEUTICS
* INVESTOR GROUP - URGES PASITHEA THERAPEUTICS BOARD TO
SCHEDULE
SPECIAL MEETING WITHOUT FURTHER DELAY
Source text for Eikon: ID:nBw7qsWL4a
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement